Video Capture and Synchronisation System - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Video Capture and Synchronisation System

Pharmaceutical Technology
Volume 37, Issue 10, pp. 18
Untitled Document

A video system provides texture analysis data and analysis capabilities for pharmaceutical and supplement manufacturers. The Video Capture and Synchronisation System can record tests and replay them frame by frame simultaneously with their corresponding force-distance-time graphs. The system includes a moveable video camera, a transparent test platform, and an optional light attachment. To conduct a test, the camera is positioned in the most appropriate location for testing. As the TA.XT plus texture analyser begins collecting data, a signal is relayed to the Video Capture Interface, which initiates recording at up to 50 frames per second. Data is collected and analyzed by Exponent Stable Micro Systems’ proprietary software.

Stable Micro Systems

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
29%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here